Nucleoside reverse transcriptase inhibitor

This page covers all Nucleoside reverse transcriptase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Hepatitis B virus reverse transcriptase, Hepatitis B virus DNA polymerase, HIV-1 reverse transcriptase.

Targets

Hepatitis B virus reverse transcriptase · Hepatitis B virus DNA polymerase · HIV-1 reverse transcriptase · HIV reverse transcriptase

Marketed (1)

• Blank maleate entecavir tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Virology / Hepatology
  Entecavir inhibits hepatitis B virus reverse transcriptase and protein priming, blocking viral DNA replication.

Phase 3 pipeline (2)

• telbivudine or lamivudine · Novartis · Infectious Disease
  Telbivudine and lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs) that work by inhibiting the replication of viral DNA.
• standard treatment in HIV positive · University of Guadalajara · Infectious Disease
  This drug works by inhibiting the replication of the HIV virus.

Phase 2 pipeline (1)

• Anti-Retroviral Agents · Shanghai Public Health Clinical Center · Infectious Disease
  Inhibits HIV reverse transcriptase